Veraxa Biotech Holding AG (VRXA)
$1.35-6.25%Close
FLAT
Key stats
Short interest · FINRA settlement 2026-08-14
- Market cap
- $191M
- Avg volume
- 400.5K
- Beta
- 0.26
- Short % float
- 3.00%
- Days to cover
- 3.6
- SI change
- -5.3%
- 1W
- -30.77%
- 1M
- -31.12%
- YTD
- -92.20%
- vs SPY 1W
- -31.24%
- vs SPY 1M
- -34.85%
- vs SPY YTD
- -104.81%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- TCRXSELLTScan Therapeutics, Inc.RECOVERYQ -14$0.75+0.00%
- EUDASELLEUDA Health Holdings LimitedCRISISQ -9$14.62-2.73%
- CUESELLCue Biopharma, Inc.RECOVERYQ -0$27.88-0.99%
- VVOSSELLVivos Therapeutics, Inc.CRISISQ -17$0.22-15.38%
- CLPTBUYClearPoint Neuro, Inc.RECOVERYQ 7$15.55-2.45%
- VSEESELLVSee Health, Inc.CRISISQ -31$0.02+0.00%
- BLRXSELLBioLineRx Ltd.CRISISQ 1$2.60-5.80%
- CYHSELLCommunity Health Systems, Inc.RECOVERYQ -1$2.93+0.00%
- DNASELLGinkgo Bioworks Holdings, Inc.CRISISQ -20$6.96-4.13%
- HELPBUYCybin Inc. Common StockRECOVERYQ 5$12.18-8.01%
- IRDBUYOpus Genetics, Inc.CRISISQ -0$3.69-4.16%
- CSBRSELLChampions Oncology, Inc.CRISISQ 12$4.93-1.79%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 0
- VALUE
- 0
- GROWTH
- 0
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-
REV YoY-
ROE-
EPS YoY-
ROA-
---
[VALUATION]
P/E TTM-
P/E FWD-
SECTOR PE22.24
INDUSTRY PE17.04
P/B-
P/FCF-
EV/EBITDA-
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO-
ND/EBITDA-
BETA0.26














